+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Smart Biopsy Market (2019-2025)

  • ID: 4871832
  • Report
  • November 2019
  • Region: Europe
  • 90 Pages
  • Marqual IT Solutions Pvt. Ltd (KBV Research)

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Medtronic Plc.
  • Olympus Corporation
The Europe Smart Biopsy Market is expected to witness market growth of 4.92% CAGR during the forecast period (2019-2025).

Novel non-invasive tools have been developed which allow the characterization of cancer tissue in real-time. These tools are referred to as smart biopsies and have already been used in several hospitals to speed up cancer diagnosis. Bringing these projects from the laboratory bench into a medical setting will make cancer diagnosis faster and cheaper, leading to earlier access to the right treatment for patients and providing a clear opportunity for players to get them there.

One of the challenges of carrying out surgery on a brain tumor is that it is necessary to prevent any damage to the blood vessels. The reason being, such damages can cause bleeding and even prove to be fatal. Through advancements in brain imaging surgeons can navigate their method accurately - this has made surgical procedures much safer. With the development of a new high-tech biopsy needle that carries a tiny imaging probe inside to help guide the way, biopsy procedures are now expected to become smoother.

In addition, growing awareness of various diseases, particularly among women with an unhealthy lifestyle, is expected to boost the demand for smart biopsy devices. As per the National Center for Biotechnology Information (NCBI), one of the most common cancers among women in Europe is cervical cancer, primarily among women over the age of 45.

Based on Application, the market is segmented into Breast cancer, Skin cancer, Liver cancer, Prostate cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Danaher Corporation, Argon Medical Devices, Inc., Cardinal Health, Inc., Canon, Inc. (Canon Medical Systems Corporation), Boston Scientific Corporation, Olympus Corporation, Hologic, Inc., B. Braun Melsungen AG, Cook Medical, Inc. (Cook Group) and Medtronic Plc.

Scope of the Study

Market Segmentation:

By Application
  • Breast cancer
  • Skin cancer
  • Liver cancer
  • Prostate cancer and
  • Others

By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled
  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.

Unique Offerings from the Publisher
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • B. Braun Melsungen AG
  • Cardinal Health, Inc.
  • Danaher Corporation
  • Hologic, Inc.
  • Medtronic Plc.
  • Olympus Corporation

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Smart Biopsy Market, by Application
1.4.2 Europe Smart Biopsy Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Market Analysis
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches
3.2.3 Expansions
3.2.4 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition and Mergers : 2019-Nov - 2016-May) Leading Players
Chapter 4. Europe Smart Biopsy Market by Application
4.1 Europe Breast cancer Market by Country
4.2 Europe Skin cancer Market by Country
4.3 Europe Liver cancer Market by Country
4.4 Europe Prostate cancer Market by Country
4.5 Europe Others Market by Country
Chapter 5. Europe Smart Biopsy Market by Country
5.1 Germany Smart Biopsy Market
5.1.1 Germany Smart Biopsy Market by Application
5.2 UK Smart Biopsy Market
5.2.1 UK Smart Biopsy Market by Application
5.3 France Smart Biopsy Market
5.3.1 France Smart Biopsy Market by Application
5.4 Russia Smart Biopsy Market
5.4.1 Russia Smart Biopsy Market by Application
5.5 Spain Smart Biopsy Market
5.5.1 Spain Smart Biopsy Market by Application
5.6 Italy Smart Biopsy Market
5.6.1 Italy Smart Biopsy Market by Application
5.7 Rest of Europe Smart Biopsy Market
5.7.1 Rest of Europe Smart Biopsy Market by Application
Chapter 6. Company Profiles
6.1 Danaher Corporation
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments
6.1.5.1 Product Launches
6.1.5.2 Acquisition and Mergers
6.1.6 SWOT Analysis
6.2 Argon Medical Devices, Inc.
6.2.1 Company Overview
6.2.1 Recent strategies and developments
6.2.1.1 Partnerships, Collaborations, and Agreements
6.2.1.2 Acquisition and Mergers
6.3 Cardinal Health, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Recent strategies and developments
6.3.4.1 Acquisition and Mergers
6.4 Canon, Inc. (Canon Medical Systems Corporation)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent strategies and developments
6.4.5.1 Product Launches
6.4.5.2 Acquisition and Mergers
6.4.5.3 Expansions
6.4.6 SWOT Analysis
6.5 Boston Scientific Corporation
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.5.5 Recent strategies and developments
6.5.5.1 Product Launches
6.5.5.2 Acquisition and Mergers
6.5.5.3 Expansions
6.5.6 SWOT Analysis
6.6 Olympus Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.6.5 Recent strategies and developments
6.6.5.1 Partnerships, Collaborations, and Agreements
6.6.5.2 Acquisition and Mergers
6.7 Hologic, Inc.
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments
6.7.5.1 Product Launches
6.7.5.2 Partnerships, Collaborations, and Agreements
6.7.5.3 Acquisition and Mergers
6.7.6 SWOT Analysis
6.8 B. Braun Melsungen AG
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Cook Medical, Inc. (Cook Group)
6.9.1 Company Overview
6.9.2 Recent strategies and developments
6.9.2.1 Product Launches
6.1 Medtronic PLC
6.10.1 Company overview
6.10.2 Financial Analysis
6.10.3 Segmental and Regional Analysis
6.10.4 Research & Development Expenses
6.10.5 Recent strategies and developments
6.10.5.1 Product Launches
6.10.5.2 Acquisition and Mergers
6.10.6 SWOT Analysis
Note: Product cover images may vary from those shown
  • Danaher Corporation
  • Argon Medical Devices, Inc.
  • Cardinal Health, Inc.
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Boston Scientific Corporation
  • Olympus Corporation
  • Hologic, Inc.
  • B. Braun Melsungen AG
  • Cook Medical, Inc. (Cook Group)
  • Medtronic Plc.
Note: Product cover images may vary from those shown

Loading
LOADING...